Alert detail
FDA Approval: MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) — Type 4 - New Combination
Policy ID: FDA-NDA021078Specialty: Infectious DiseaseAdded: 6/13/2026Effective: 2000-07-14federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.